This inventor holds 1 USPTO granted patent. Top assignee: Metagen Pharmaceuticals Gmbh. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Edgar Dahl: Inventor in Biotechnology
Introduction
Edgar Dahl is an inventor associated with Potsdam, Germany, and Metagen Pharmaceuticals GmbH. His patent work concerns nucleic acid sequences derived from endometrial tumor tissue and their potential uses.
Latest Patents
Dahl is associated with 1 patent, titled “Human Nucleic Acid Sequences from Endometrial Tumor Tissue.” The patent describes mRNA, cDNA, and genomic sequences from endometrial tumor tissue that code for gene products or portions of them. It also covers polypeptides obtainable through these sequences and their uses.
Career Highlights
Dahl’s documented patent activity focuses on molecular biology and the characterization and application of genetic material from endometrial tumors. His work is associated with Metagen Pharmaceuticals GmbH.
Collaborations
Dahl’s listed coworkers include Bernd Hinzmann and Armin Schmitt.
Conclusion
Edgar Dahl’s recorded invention centers on nucleic acid sequences and related polypeptides from endometrial tumor tissue, reflecting a biotechnology-focused contribution associated with Metagen Pharmaceuticals GmbH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile